Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma (Q79284465)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Heng Ge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jun-Feng Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Bing-Shi Guo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Qing He

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Bin-Yao Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ben He

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Chang-Qian Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

3 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

114-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Matrix metalloproteinases and coronary artery diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the beta-chain of major histocompatibility complex class II antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Vulnerable atherosclerotic plaque: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

PPARgamma and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.08.412

10.1016/J.VPH.2006.08.412

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055343%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference